Showing results (361-370 of 723) with videos related to
Sort By:
Pageof 73
Current Medicinal Chemistry|September 3, 2013
Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancersG Ilardi, N Zambrano, F Merolla, et al.New Microbes and New Infections|April 17, 2019
V348I mutation in UL23 gene of human herpesvirus 1 in a case of herpetic hepatitis and haemophagocytic lymphohistiocytosisS Corcione, F Sidoti, C Costa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious DiseasesD J Straus, J Huang, M A Testa, et al.Public Health Reports (Washington, D.C. : 1974)|May 24, 2007
Development of a survey instrument to measure connectivity to evaluate national public health preparedness and response performanceBarry C Dorn, Elena Savoia, Marcia A Testa, et al.Plos One|November 27, 2013
Non-invasive imaging of tumors by monitoring autotaxin activity using an enzyme-activated near-infrared fluorogenic substrateDamian Madan, Colin G Ferguson, Won Yong Lee, et al.Arthritis and Rheumatism|June 1, 1985
A comparison of the specificity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosusC M Passas, R L Wong, M Peterson, et al.American Journal of Preventive Medicine|January 7, 1998
Modeling fracture risk using bone density, age, and years since menopauseJ Carroll, M A Testa, K Erat, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 1, 1995
Reproducibility of DXA absorptiometry: a model for bone loss estimatesG E Fuleihan, M A Testa, J E Angell, et al.In Vivo (Athens, Greece)|November 1, 1991
Intracavitary beta-interferon for the management of pleural and/or abdominal effusions in patients with advanced cancer refractory to chemotherapyV Gebbia, A Russo, N Gebbia, et al.Tumori|February 28, 1994
Mitomycin "C" and vinorelbine as second line chemotherapy for metastatic breast carcinomaB Agostara, V Gebbia, A Testa, et al.Pageof 73